GRAF ACQUISITION PARTNERS IV LLC (Chief Executive Officer) reported 1 transaction at NKGEN BIOTECH, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 6/2/2021ACC: 0001104659-21-075828
Officer10% Owner· Chief Executive Officer
Since May 2021
-22.13K
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
22.13K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−22.13K
Price / share
—
Trade value
—
% of position
0.5%
6/2/2021
4.25M→4.23M
Total
Net shares
−22.13K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/2/2021 | J · J | −22.13K | — | — | 0.5% | 4.25M | 4.23M |
| Total | −22.13K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported